The role of cytidine 5′‐triphosphate synthetase 1 in metabolic rewiring during epithelial‐to‐mesenchymal transition in non‐small‐cell lung cancer
FEBS Open Bio · 2024
DOI: 10.1002/2211-5463.13860 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2024. Verfasst von Fumie Nakasuka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan. Hauptthemen laut MEDLINE: Carbon-Nitrogen Ligases, Carcinoma, Non-Small-Cell Lung, Epithelial-Mesenchymal Transition, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kanazawa University, Japan Society for the Promotion of Science, Naito Foundation.
Abstract (Originalsprache)
Epithelial‐to‐mesenchymal transition (EMT) contributes to the poor prognosis of patients with cancer by promoting distant metastasis and anti‐cancer drug resistance. Several distinct metabolic alterations have been identified as key EMT phenotypes. In the present study, we further characterize the role of transforming growth factor‐β (TGF‐β)‐induced EMT in non‐small‐cell lung cancer. Our study revealed that TGF‐β plays a role in EMT functions by upregulation of cytidine 5′‐triphosphate synthetase 1 (CTPS), a vital enzyme for CTP biosynthesis in the pyrimidine metabolic pathway. Both knockdown and enzymatic inhibition of CTPS reduced TGF‐β‐induced changes in EMT marker expression, chemoresistance and migration in vitro . Moreover, CTPS knockdown counteracted the TGF‐β‐mediated downregulation of UDP‐glucuronate, glutarate, creatine, taurine and nicotinamide. These findings indicate that CTPS plays a multifaceted role in EMT metabolism, which is crucial for the malignant transformation of cancer through EMT, and underline its potential as a promising therapeutic target for preventing drug resistance and metastasis in non‐small‐cell lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
- Systems Biology Program, Graduate School of Media and Governance, Keio University, Fujisawa, Japan.
- Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Japan.
- Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan.
- Shonai Regional Industry Promotion Center, Tsuruoka, Japan.
- Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
ORCID-Profile: Fumie Nakasuka
Förderung
- Kanazawa University
- Japan Society for the Promotion of Science
- Naito Foundation
- Mori Memorial Research Fund
- Yamagishi Student Project Support Program of Keio University
- Yamagata Prefecture Government and City of Tsuruoka, Japan
Zitieren
APA
Nakasuka, F., Hirayama, A., Makinoshima, H., Yano, S., Soga, T., & Tabata, S. (2024). The role of cytidine 5′‐triphosphate synthetase 1 in metabolic rewiring during epithelial‐to‐mesenchymal transition in non‐small‐cell lung cancer. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13860
Vancouver
Nakasuka F, Hirayama A, Makinoshima H, Yano S, Soga T, Tabata S. The role of cytidine 5′‐triphosphate synthetase 1 in metabolic rewiring during epithelial‐to‐mesenchymal transition in non‐small‐cell lung cancer. FEBS Open Bio. 2024. doi:10.1002/2211-5463.13860
BibTeX
@article{Nakasuka2024,
author = {Nakasuka, Fumie and Hirayama, Akiyoshi and Makinoshima, Hideki and Yano, Seiji and Soga, Tomoyoshi and Tabata, Sho},
title = {The role of cytidine 5′‐triphosphate synthetase 1 in metabolic rewiring during epithelial‐to‐mesenchymal transition in non‐small‐cell lung cancer},
journal = {FEBS Open Bio},
year = {2024},
doi = {10.1002/2211-5463.13860}
}
EUVIMED